In hematological diseases, the strong expression of ROR1 has been described in CLL and mantle cell lymphoma (MCL), while moderate and heterogeneous expression has been noted in marginal zone lymphoma, DLBCL, and follicular lymphoma [85,86,87]. Here, ROR1 is linked to mantle cell lymphoma.